Pulmonary Clinical Trial - Nuvaira, Inc.

Pulmonology

Status:

active and enrolling

ClinicalTrials.gov:

NCT03639051

NUVAIRA AF3

Device

Targeted Lung Denervation (TLD)/Optimal Medical Care

Phase

N/A

Condition

COPD